DDI-DrugBank.d741.s0 >> In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving methadone, treatment with PEG-Intron once weekly for 4 weeks was associated with a mean increase of 16% in methadone AUC; >> 86-94,112-121,193-201
DDI-DrugBank.d741.s1 >> in 2 out of 18 patients, methadone AUC doubled. >> 25-33
DDI-DrugBank.d741.s2 >> The clinical significance of this finding is unknown;
DDI-DrugBank.d741.s3 >> however, patients should be monitored for the signs and symptoms of increased narcotic effect.
